Systemic Tranexamic Acid for Reduced Postoperative Blood Loss and Less Bleeding Complications in Fleur-de-lis Abdominoplasty and Apronectomy.

Aesthetic plastic surgery 2024 Vol.48(13) p. 2465-2474

Wachtel C, Rothenberger J, Ederer IA, Souquet J, Rieger U

관련 도메인

Abstract

[BACKGROUND] Strategies minimizing surgical bleeding, including the antifibrinolytic agent tranexamic acid, play a crucial role in clinical practice to optimize overall surgical outcomes. Despite its proven efficacy in various clinical fields, there is a limited understanding regarding the use of tranexamic acid in plastic and aesthetic procedures. This study is the first investigating the effects of systemically administered tranexamic acid on postoperative blood loss and bleeding complications in fleur-de-lis abdominoplasties and apronectomies.

[METHODS] Patients who received 1 g tranexamic acid (n = 44) during fleur-de-lis abdominoplasty or apronectomy were retrospectively compared with those who did not (n = 44). In this context, the outcome parameters 24-h and total drain fluid production, drain time, hospital stay, absolute and relative drop in hemoglobin and hematocrit level as well as bleeding complications such as blood transfusion, hematoma puncture and evacuation were evaluated.

[RESULTS] Tranexamic acid significantly decreased both drainage volume in 24 h (40.5%, p = 0.0046) and total drain fluid production (42.5%, p = 0.0017). Moreover, a shorter drainage time (19.4%, p = 0.0028) and hospital stay (21.4%, p = 0.0009) were observed. The administration of tranexamic acid was also associated with a reduced postoperative decline in hemoglobin and hematocrit levels. Notably, no bleeding complications were observed in patients who received tranexamic acid, while 6 events occurred in patients without (p = 0.0262).

[CONCLUSION] Systemic administration of tranexamic acid effectively reduced postoperative blood loss and bleeding complications in fleur-de-lis abdominoplasties and apronectomies.

[LEVEL OF EVIDENCE IV] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
약물 tranexamic acid 트라넥삼산 dict 9
시술 abdominoplasty 복부성형술 dict 2
해부 Blood scispacy 1
해부 hematocrit scispacy 1
합병증 Fleur-de-lis Abdominoplasty scispacy 1
합병증 hematoma puncture scispacy 1
합병증 hematoma 혈종 dict 1
약물 [BACKGROUND] Strategies scispacy 1
약물 [RESULTS] Tranexamic acid scispacy 1
질환 Reduced Postoperative Blood Loss C0032788
Postoperative Hemorrhage
scispacy 1
질환 Bleeding C0019080
Hemorrhage
scispacy 1
질환 postoperative blood loss C0032788
Postoperative Hemorrhage
scispacy 1
질환 a reduced postoperative decline scispacy 1
기타 Patients scispacy 1
기타 hemoglobin scispacy 1

MeSH Terms

Humans; Tranexamic Acid; Abdominoplasty; Female; Retrospective Studies; Antifibrinolytic Agents; Postoperative Hemorrhage; Middle Aged; Male; Adult; Treatment Outcome; Cohort Studies; Risk Assessment; Length of Stay; Blood Loss, Surgical

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문